Cureus Updates Terms & Conditions to Prohibit AI Use
Comunicato Precedente
Comunicato Successivo
"In connection with your Use of the Site Content, you must…not use the Site Content in combination with artificial intelligence…to train an algorithm, machine learning tool, or other artificial intelligence technology."
This isn't just a legal change — it's a declaration of values. Cureus believes authorship is a human right, and we're committed to preserving the originality and intellectual integrity of every article we publish.
"We're not anti-technology. We're pro-human. We're not anti-progress. We're pro-author. In an age where machines can replicate text, but not insight, Cureus remains committed to amplifying authentic scientific voices. Because real knowledge isn't just generated– it's discovered, tested, and told by humans."
- Professor John Adler, MD.
(co-founder, co-editor-in-chief)
Founded to democratize medical publishing, Cureus eliminates traditional barriers like APCs and paywalls. As part of Springer Nature, Cureus continues to lead innovation in open-access publishing.
Fast facts about Cureus:
Media Contact:
Cureus Editorial Office
Email: info@cureus.com
Website: www.cureus.com
View original content:https://www.prnewswire.co.uk/news-releases/cureus-updates-terms--conditions-to-prohibit-ai-use-302546487.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




